Phorbol Ester Activation of the Rat Vascular Myocyte Na+-H+ Exchanger Isoform

Hypertension

Volumn 27, Issue 4, 1996, Pages 859-866

  Siczkowski, Martin ^a   Ng, Leong L ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Na+ H+ exchanger; Phorbol esters; Phosphorylation; Vascular myocytes

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; PROTON; SODIUM ION;

ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HYPERTENSION; ION EXCHANGE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; PHORBOL ESTERS; PHOSPHORYLATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SODIUM-HYDROGEN ANTIPORTER;

EID: 0029920876     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.4.859     Document Type: Article

References (32)

1. + exchanger and its role in essential hypertension and diabetes mellitus. Diabetes Care. 1991;14:521-535.
2. Rosskopf D, Dusing R, Siffert W. Membrane sodium-proton exchange and primary hypertension. Hypertension. 1993;21:607-617.
3. + antiporter activity and an altered skeletal muscle contractile response in the spontaneously hypertensive rat. J Hypertens. 1990;8:1027-1036.
4. + antiport activity in cultured skeletal muscle cells and vascular smooth muscle cells from the spontaneously hypertensive rat. Clin Sci. 1991;80:509-516.
5. Berk BC, Vallega G, Muslin AJ, Gordon HM, Canessa M, Alexander RW. Spontaneously hypertensive rat vascular smooth muscle cells in culture exhibit increased growth and Na-H exchange. J Clin Invest. 1989;83:822-829.
6. + antiporter (NHE-1 isoform) in cultured vascular smooth muscle from the spontaneously hypertensive rat. Kidney Int . 1995;47:78-87.
7. Yamori Y, Igawa T, Tagami M, Kanbe T, Nara Y, Kihara M, Horie R. Humoral trophic influences on cardiovascular structural changes in hypertension. Hypertension. 1984;6(suppl III):III-27-III-32.
8. Scott-Burden T, Resink TJ, Baur U, Burgin M, Buhler FR. Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension. 1989;13:295-304.
9. Scott-Burden T, Resink TJ, Buhler FR. Enhanced growth and growth factor responsiveness of vascular smooth muscle cells from hypertensive rats. J Cardiovasc Pharmacol. 1989;14(suppl 6):S16-S21.
10. Resink TJ, Scott-Burden T, Baur U, Burgin M, Buhler FR. Enhanced responsiveness to angiotensin II in vascular smooth muscle cells from spontaneously hypertensive rats is not associated with alterations in protein kinase C. Hypertension. 1989;14:293-303.
11. + exchanger expression in vascular smooth muscle of spontaneously hypertensive and Wistar-Kyoto rats. Hypertension . 1994;24:734-738.
12. + antiporter protein in normal Wistar-Kyoto and spontaneously hypertensive rat. J Hypertens . 1994;12:775-781.
13. + antiporter, a glycoprotein of 110 kD. Science . 1990;247:723-726.
14. + exchanger, NHE-1, by phosphorylating a set of common sites. J Biol Chem . 1991;266:19166-19171.
15. + antiport. J Biol Chem. 1991;266:15406-15413.
16. Orlowski J, Kandasamy RA, Shull GE. Molecular cloning of putative members of the Na/H exchanger gene family. J Biol Chem. 1992;267:9331-9339.
17. Bruschi G, Bruschi ME, Capelli P, Regolisti G, Borghetti A. Increased sensitivity to protein kinase C activation in aortas of spontaneously hypertensive rats. J Hypertens. 1988;6(suppl 4):S248-S251.
18. Silver PJ, Lepore RE, Cumiskey WR, Kiefer D, Harris AL. Protein kinase C activity and reactivity to phorbol ester in vascular smooth muscle from spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto rats (WKY). Biochem Biophys Res Commun. 1988;154:272-277.
19. Buchholz RA, Dundore RL Cumiskey WR, Harris AL, Silver PJ. Protein kinase inhibitors and blood pressure control in spontaneously hypertensive rats. Hypertension. 1991;17:91-100.
20. Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE. Potent selective inhibitors of protein kinase C . FEBS Lett. 1989;259:61-63.
21. + antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. J Clin Invest. 1994;93:2750-2757.
22. + antiporter in normal and transformed human lymphocytes and fibroblasts. Am J Physiol. 1994;267:C745-C752.
23. + exchanger isotorm 1 phosphorylation in normal Wistar-Kyoto and spontaneously hypertensive rats. Circ Res . 1995-76:825-831.
24. + antiporter phenotype, abundance and phosphorylation of immortalized lymphoblasts from humans with hypertension. Hypertension. 1995;25:971-977.
25. + antiport is activated by serum and phorbol esters in proliferating myoblasts hut not in differentiated myotubes. J Biol Chem. 1985;260:8008-8013.
26. + exchanger. Am J Physiol 1993;264:C944-C950.
27. + exchange in renal microvillus membrane vesicles. Nature. 1982;299:161-163.
28. Rosskopf D, Fromter E, Siffert W. Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients: a cell culture model for human hypertension. J Clin Invest. 1993;92:2553-2559.
29. + antiporter is not stimulated by phorbol ester and acidification in granulocytic HL-60 cells. Am J Physiol . 1993;264:C1278-C1284.
30. + antiporter during cell volume regulation. J Biol Chem. 1992;267:23823-23828.
31. + exchanger isoform 1 (NHE1). J Biol Chem. 1994;269:5583-5588.
32. + exchanger isoform 1 (NHE1) is a novel member of the calmodulin-binding proteins: identification and characterization of calmodulin-binding sites. J Biol Chem . 1994;269:13703-13709.